Cedar Mountain Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Cedar Mountain Advisors's DGX Position: Q3 2026 in Review
Cedar Mountain Advisors reduced its Quest Diagnostics (DGX) stake by 15% in Q3 2026, selling an estimated $1.16K and leaving 28 shares worth $6.53K. The position accounts for ﹤0.01% of the portfolio, ranked #576.
Cedar Mountain Advisors first reported a position in DGX in Q4 2019 and has held it in 28 quarters since. The position peaked at $10.3K in Q1 2025. 266 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Cedar Mountain Advisors held 28 shares of Quest Diagnostics worth $6.53K as of Q3 2026.
- Cedar Mountain Advisors sold 5 Quest Diagnostics shares in Q3 2026, an estimated $1.16K.
- Quest Diagnostics made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q3 2026, its #576 holding.
- Cedar Mountain Advisors first reported a position in Quest Diagnostics in Q4 2019 and has held it in 28 quarters since.
- Cedar Mountain Advisors's Quest Diagnostics position peaked at $10.3K in Q1 2025.
- 266 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Cedar Mountain Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.